Natural History of "Pure" Primary Lateral Sclerosis
- PMID: 33637635
- PMCID: PMC8166429
- DOI: 10.1212/WNL.0000000000011771
Natural History of "Pure" Primary Lateral Sclerosis
Abstract
Objective: To assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up.
Methods: Retrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990-2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms.
Results: Forty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38-78 years) and median follow-up at 9 years' disease duration (range 4-36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; p = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs.
Conclusions: Pure PLS did not convert to ALS after a median of 9 years' disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, <5% develop a more pervasive neurodegenerative disorder.
© 2021 American Academy of Neurology.
Comment in
-
The Benign Course of PLS: A Strong Point in Favor of an Earlier Differentiation From ALS.Neurology. 2021 Apr 27;96(17):783-784. doi: 10.1212/WNL.0000000000011773. Epub 2021 Feb 26. Neurology. 2021. PMID: 33637628 No abstract available.
Similar articles
-
Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis?Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):554-561. doi: 10.1080/21678421.2022.2039714. Epub 2022 Feb 16. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35170382
-
Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.Neurodegener Dis Manag. 2018 Feb;8(1):17-23. doi: 10.2217/nmt-2017-0051. Epub 2018 Jan 10. Neurodegener Dis Manag. 2018. PMID: 29316850 Review.
-
Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.Arch Neurol. 2007 Feb;64(2):232-6. doi: 10.1001/archneur.64.2.232. Arch Neurol. 2007. PMID: 17296839
-
Primary Lateral Sclerosis: Implications for Diagnostic Criteria From a Natural History Study in the Netherlands.Neurology. 2025 Jun 10;104(11):e213461. doi: 10.1212/WNL.0000000000213461. Epub 2025 May 19. Neurology. 2025. PMID: 40388677 Free PMC article.
-
[Primary lateral sclerosis: the era of international diagnosis criteria].Rev Neurol (Paris). 2009 May;165(5):415-29. doi: 10.1016/j.neurol.2008.07.022. Epub 2008 Oct 7. Rev Neurol (Paris). 2009. PMID: 18842276 Review. French.
Cited by
-
Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study.Brain Pathol. 2025 Jan;35(1):e13286. doi: 10.1111/bpa.13286. Epub 2024 Jul 10. Brain Pathol. 2025. PMID: 38988008 Free PMC article.
-
Altered Metabolism in Motor Neuron Diseases: Mechanism and Potential Therapeutic Target.Cells. 2023 Jun 2;12(11):1536. doi: 10.3390/cells12111536. Cells. 2023. PMID: 37296656 Free PMC article. Review.
-
Primary Lateral Sclerosis: An Overview.J Clin Med. 2024 Jan 19;13(2):578. doi: 10.3390/jcm13020578. J Clin Med. 2024. PMID: 38276084 Free PMC article. Review.
-
Diagnosing primary lateral sclerosis: a clinico-pathological study.J Neurol. 2024 Dec 12;272(1):46. doi: 10.1007/s00415-024-12816-0. J Neurol. 2024. PMID: 39666071
-
Autonomic impairment in primary lateral sclerosis.Clin Auton Res. 2024 Aug;34(4):421-425. doi: 10.1007/s10286-024-01039-y. Epub 2024 Jun 12. Clin Auton Res. 2024. PMID: 38865034
References
-
- Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007;35:291–302. - PubMed
-
- Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol 2007;64:232–236. - PubMed
-
- Stark FM, Moersch FP. Primary lateral sclerosis: a distinct clinical entity. J Nervous Ment Dis 1945;102:332–337.
-
- Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495–520. - PubMed
-
- Gordon PH, Cheng B, Katz IB, et al. . The natural history of primary lateral sclerosis. Neurology 2006;66:647–653. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous